(Total Views: 118)
Posted On: 07/19/2021 9:55:48 AM
Post# of 47163
$CYDY News Article - CytoDyn Announces Preliminary Results from 30 mTNBC Patients Treated with Leronlimab. Decreases in CAMLs after 4 Doses of Leronlimab were Identified in Over 70% of Patients and were Associated with a 450% Significant Increase in Overall Survival at 12-Mon https://marketwirenews.com/news-releases/cyto...88230.html
(0)
(0)
My Twitter: WhyteStocks
